Regulation and function of selenoproteins in human disease

Biochemical Journal

Volumn 422, Issue 1, 2009, Pages 11-22

  Bellinger, Frederick P ^a   Raman, Arjun V ^a   Reeves, Mariclair A ^a   Berry, Marla J ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Cancer; Diabetes; Keshan disease; Multiminicore disease; Neurodegeneration; Selenium; Selenocysteine; Selenoprotein; Thyroid hormone

Indexed keywords

CANCER; DIABETES; KESHAN DISEASE; MULTIMINICORE DISEASE; NEURODEGENERATION; SELENOCYSTEINE; SELENOPROTEIN; THYROID HORMONE;

AMINES; AMINO ACIDS; CELL MEMBRANES; HORMONES; ORGANIC ACIDS; PROTEINS;

SELENIUM;

ALPHA TOCOPHEROL; BINDING PROTEIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE PEROXIDASE 4; IODOTHYRONINE DEIODINASE; OXIDOREDUCTASE; SELENIUM; SELENOCYSTEINE INSERTION SEQUENCE BINDING PROTEIN 2; SELENOCYSTINE; SELENOPROTEIN; SELENOPROTEIN M; SELENOPROTEIN N; SELENOPROTEIN P; SELENOPROTEIN S; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; THYROID HORMONE; TOPIRAMATE; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ALZHEIMER DISEASE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIET SUPPLEMENTATION; DNA POLYMORPHISM; DRUG MECHANISM; ENDOCRINE DISEASE; EPILEPSY; GENE EXPRESSION REGULATION; GENE MUTATION; HEART FUNCTION; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; KESHAN DISEASE; MULTIMINICORE DISEASE; MUSCLE DISEASE; NEOPLASM; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; OSTEOARTHROPATHY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; REVIEW; SELENIUM DEFICIENCY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THYROID DISEASE;

DISEASE; HUMANS; SELENOPROTEINS;

EID: 68749110874     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20090219     Document Type: Review

References (220)

1. Small-Howard, A. L. and Berry, M. J. (2005) Unique features of selenocysteine incorporation function within the context of general eukaryotic translational processes. Biochem. Soc. Trans. 33, 1493-1497
2. Berry, M. J., Tujebajeva, R. M., Copeland, P. R., Xu, X. M., Carlson, B. A., Martin, 3rd, G. W., Low, S. C., Mansell, J. B., Grundner-Culemann, E., Harney, J. W. et al. (2001) Selenocysteine incorporation directed from the 3′UTR: characterization of eukaryotic EFsec and mechanistic implications. Biofactors 14, 17-24
3. Forstrom, J. W., Zakowski, J. J. and Tappel, A. L. (1978) Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteine. Biochemistry 17, 2639-2644
4. Chambers, I., Frampton, J., Goldfarb, P., Affara, N., McBain, W. and Harrison, P. R. (1986) The structure of the mouse glutathione peroxidase gene: the selenocysteine in the active site is encoded by the 'termination' codon, TGA. EMBO J. 5, 1221-1227
5. Zinoni, F., Birkmann, A., Stadtman, T. C. and Bock, A. (1986) Nucleotide sequence and expression of the selenocysteine-containing polypeptide of formate dehydrogenase (formate-hydrogen-lyase-linked) from Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 83, 4650-4654
6. Zinoni, F., Birkmann, A., Leinfelder, W. and Bock, A. (1987) Cotranslational insertion of selenocysteine into formate dehydrogenase from Escherichia coli directed by a UGA codon. Proc. Natl. Acad. Sci. U.S.A. 84, 3156-3160
7. Berry, M. J., Banu, L., Harney, J. W. and Larsen, P. R. (1993) Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J. 12, 3315-3322
8. Low, S. C. and Berry, M. J. (1996) Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem. Sci. 21, 203-208
9. Schwarz, K. and Foltz, C. M. (1958) Factor 3 activity of selenium compounds. J. Biol. Chem. 233, 245-251
10. Papp, L. V., Lu, J., Holmgren, A. and Khanna, K. K. (2007) From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid. Redox Signaling 9, 775-806
11. Arthur, J. R. (2000) The glutathione peroxidases. Cell. Mol. Life Sci. 57, 1825-1835
12. Tamura, T. and Stadtman, T. C. (2002) Mammalian thioredoxin reductases. Methods Enzymol. 347, 297-306
13. Beckett, G. J. and Arthur, J. R. (2005) selenium and endocrine systems. J. Endocrinol. 184, 455-465
14. Motsenbocker, M. A. and Tappel, A. L. (1982) A selenocysteine-containing selenium-transport protein in rat plasma. Biochim. Biophys. Acta 719, 147-153
15. Vendeland, S. C., Beilstein, M. A., Chen, C. L., Jensen, O. N., Barofsky, E. and Whanger, P. D. (1993) Purification and properties of selenoprotein W from rat muscle. J. Biol. Chem. 268, 17103-17107
16. Burk, R. F. and Hill, K. E. (2005) Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu. Rev. Nutr. 25, 215-235
17. Beilstein, M. A., Vendeland, S. C., Barofsky, E., Jensen, O. N. and Whanger, P. D. (1996) Selenoprotein W of rat muscle binds glutathione and an unknown small molecular weight moiety. J. Inorg. Biochem. 61, 117-124
18. Panee, J., Stoytcheva, Z., Liu, W. and Berry, M. (2007) Selenoprotein H is a redox-sensing high mobility group family DNA-binding protein that up-regulates genes involved in glutathione synthesis and phase II detoxification. J. Biol. Chem. 282, 23759-23765
19. Horibata, Y. and Hirabayashi, Y. (2007) Identification and characterization of human ethanolaminephosphotransferase1. J. Lipid Res. 48, 503-508
20. Petit, N., Lescure, A., Rederstorff, M., Krol, A., Moghadaszadeh, B., Wewer, U. M. and Guicheney, P. (2003) Selenoprotein N: an endoplasmic reticulum glycoprotein with an early developmental expression pattern. Hum. Mol. Genet. 12, 1045-1053
21. Bar-Nun, S. (2005) The role of p97/Cdc48p in endoplasmic reticulum-associated degradation: from the immune system to yeast. Curr. Top. Microbiol. Immunol. 300, 95-125
22. Reeves, M. A. and Hoffmann, P. R. (2009) The human selenoproteome: recent insights into functions and regulation. Cell. Mol. Life Sci., doi:10.1007/s00018-009-0032-4
23. Boosalis, M. G. (2008) The role of selenium in chronic disease. Nutr. Clin. Pract. 23, 152-160
24. Papp, L. V., Wang, J., Kennedy, D., Boucher, D., Zhang, Y., Gladyshev, V. N., Singh, R. N. and Khanna, K. K. (2008) Functional characterization of alternatively spliced human SECISBP2 transcript variants. Nucleic Acids Res. 36, 7192-7206
25. Squires, J. E. and Berry, M. J. (2008) Eukaryotic selenoprotein synthesis: mechanistic insight incorporating new factors and new functions for old factors. IUBMB Life 60, 232-235
26. de Jesus, L. A., Hoffmann, P. R., Michaud, T., Forry, E. P., Small-Howard, A., Stillwell, R. J., Morozova, N., Harney, J. W. and Berry, M. J. (2006) Nuclear assembly of UGA decoding complexes on selenoprotein mRNAs: a mechanism for eluding nonsense-mediated decay? Mol. Cell. Biol. 26, 1795-1805
27. Squires, J. E., Stoytchev, I., Forry, E. P. and Berry, M. J. (2007) SBP2 binding affinity is a major determinant in differential selenoprotein mRNA translation and sensitivity to nonsense-mediated decay. Mol. Cell. Biol. 27, 7848-7855
28. Papp, L. V., Lu, J., Striebel, F., Kennedy, D., Holmgren, A. and Khanna, K. K. (2006) The redox state of SECIS binding protein 2 controls its localization and selenocysteine incorporation function. Mol. Cell. Biol. 26, 4895-4910
29. Ding, F. and Grabowski, P. J. (1999) Identification of a protein component of a mammalian tRNA(Sec) complex implicated in the decoding of UGA as selenocysteine. RNA 5, 1561-1569
30. Wu, R., Shen, Q. and Newburger, P. E. (2000) Recognition and binding of the human selenocysteine insertion sequence by nucleolin. J. Cell. Biochem. 77, 507-516
31. Fan, L., Jones, S. N., Padden, C., Shen, Q. and Newburger, P. E. (2006) Nuclease sensitive element binding protein 1 gene disruption results in early embryonic lethality. J. Cell. Biochem. 99, 140-145
32. Shen, Q., Fan, L. and Newburger, P. E. (2006) Nuclease sensitive element binding protein 1 associates with the selenocysteine insertion sequence and functions in mammalian selenoprotein translation. J. Cell. Physiol. 207, 775-783
33. Vendeland, S. C., Beilstein, M. A., Yeh, J. Y., Ream, W. and Whanger, P. D. (1995) Rat skeletal muscle selenoprotein W: cDNA clone and mRNA modulation by dietary selenium. Proc. Natl. Acad. Sci. U.S.A. 92, 8749-8753
34. Moreno-Reyes, R., Mathieu, F., Boelaert, M., Begaux, F., Suetens, C., Rivera, M. T., Neve, J., Perlmutter, N. and Vanderpas, J. (2003) Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am. J. Clin. Nutr. 78, 137-144
35. Vanderpas, J. B., Contempre, B., Duale, N. L., Goossens, W., Bebe, N., Thorpe, R., Ntambue, K., Dumont, J., Thilly, C. H. and Diplock, A. T. (1990) Iodine and selenium deficiency associated with cretinism in northern Zaire. Am. J. Clin. Nutr. 52, 1087-1093
36. Dubois, F. and Belleville, F. (1988) Selenium: physiologic role and value in human pathology. Pathol. Biol. 36, 1017-1025
37. Laing, N. G. (2007) Congenital myopathies. Curr. Opin. Neurol. 20, 583-589
38. Jungbluth, H. (2007) Multi-minicore disease. Orphanet J. Rare Dis. 2, 31
39. Zorzato, F., Jungbluth, H., Zhou, H., Muntoni, F. and Treves, S. (2007) Functional effects of mutations identified in patients with multiminicore disease. IUBMB Life 59, 14-20
40. Moghadaszadeh, B., Petit, N., Jaillard, C., Brockington, M., Roy, S. Q., Merlini, L., Romero, N., Estournet, B., Desguerre, I., Chaigne, D. et al. (2001) Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat. Genet. 29, 17-18
41. Ferreiro, A., Quijano-Roy, S., Pichereau, C., Moghadaszadeh, B., Goemans, N., Bonnemann, C., Jungbluth, H., Straub, V., Villanova, M., Leroy, J. P. et al. (2002) Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am. J. Hum. Genet. 71, 739-749
42. Ferreiro, A., Ceuterick-de Groote, C., Marks, J. J., Goemans, N., Schreiber, G., Hanefeld, F., Fardeau, M., Martin, J. J., Goebel, H. H., Richard, P. et al. (2004) Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann. Neurol. 55, 676-686
43. Tajsharghi, H., Darin, N., Tulinius, M. and Oldfors, A. (2005) Early onset myopathy with a novel mutation in the selenoprotein N gene (SEPN1). Neuromuscul. Disord. 15, 299-302
44. Zalk, R., Lehnart, S. E. and Marks, A. R. (2007) Modulation of the ryanodine receptor and intracellular calcium. Annu. Rev. Biochem. 76, 367-385
45. Treves, S., Anderson, A. A., Ducreux, S., Divet, A., Bleunven, C., Grasso, C., Paesante, S. and Zorzato, F. (2005) Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul. Disord. 15, 577-587
46. Deniziak, M., Thisse, C., Rederstorff, M., Hindelang, C., Thisse, B. and Lescure, A. (2007) Loss of selenoprotein N function causes disruption of muscle architecture in the zebrafish embryo. Exp. Cell Res. 313, 156-167
47. Maiti, B., Arbogast, S., Allamand, V., Moyle, M. W., Anderson, C. B., Richard, P., Guicheney, P., Ferreiro, A., Flanigan, K. M. and Howard, M. T. (2008) A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy. Hum. Mutat. 30, 411-416
48. Jurynec, M. J., Xia, R., Mackrill, J. J., Gunther, D., Crawford, T., Flanigan, K. M., Abramson, J. J., Howard, M. T. and Grunwald, D. J. (2008) Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc. Natl. Acad. Sci. U.S.A. 105, 12485-12490
49. 2+ mobilization and neuroendocrine secretion. FASEB J. 22, 1756-1768
50. Reference deleted
51. Reeves, M. A., Berry, M. J. and Bellinger, F. P. (2008) The antioxidant capacity of selenoprotein M in brain cells. Neuroscience 2005 Meeting, Washington DC, U.S.A., 15-19 November 2008, Abstract 549.4/X5
52. Lum, H. and Roebuck, K. A. (2001) Oxidant stress and endothelial cell dysfunction. Am. J. Physiol. Cell Physiol. 280, C719-C741
53. Miller, S., Walker, S. W., Arthur, J. R., Nicol, F., Pickard, K., Lewin, M. H., Howie, A. F. and Beckett, G. J. (2001) Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Clin. Sci. 100, 543-550
54. Steinbrenner, H., Alili, L., Bilgic, E., Sies, H. and Brenneisen, P. (2006) Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radical Biol. Med. 40, 1513-1523
55. Tang, R., Liu, H., Wang, T. and Huang, K. (2005) Mechanisms of selenium inhibition of cell apoptosis induced by oxysterols in rat vascular smooth muscle cells. Arch. Biochem. Biophys. 441, 16-24
56. Thomas, J. P., Geiger, P. G. and Girotti, A. W. (1993) Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. J. Lipid Res. 34, 479-490
57. Huang, K., Liu, H., Chen, Z. and Xu, H. (2002) Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis 162, 137-144
58. Wu, Q. and Huang, K. (2004) Effect of long-term Se deficiency on the antioxidant capacities of rat vascular tissue. Biol. Trace Elem. Res. 98, 73-84
59. Ostadalova, I., Vobecky, M., Chvojkova, Z., Mikova, D., Hampl, V., Wilhelm, J. and Ostadal, B. (2007) Selenium protects the immature rat heart against ischemia/reperfusion injury. Mol. Cell. Biochem. 300, 259-267
60. Venardos, K., Harrison, G., Headrick, J. and Perkins, A. (2004) Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion. J. Trace Elem. Med. Biol. 18, 81-88
61. Maulik, N., Yoshida, T. and Das, D. K. (1999) Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase. Mol. Cell. Biochem. 196, 13-21
62. Forgione, M. A., Cap, A., Liao, R., Moldovan, N. I., Eberhardt, R. T., Lim, C. C., Jones, J., Goldschmidt-Clermont, P. J. and Loscalzo, J. (2002) Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 106, 1154-1158
63. Xiong, Y., Liu, X., Lee, C. P., Chua, B. H. and Ho, Y. S. (2006) Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase. Free Radical Biol. Med. 41, 46-55
64. Kenet, G., Freedman, J., Shenkman, B., Regina, E., Brok-Simoni, F., Holzman, F., Vavva, F., Brand, N., Michelson, A., Trolliet, M. et al. (1999) Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arterioscler. Thromb. Vasc. Biol. 19, 2017-2023
65. Bierl, C., Voetsch, B., Jin, R. C., Handy, D. E. and Loscalzo, J. (2004) Determinants of human plasma glutathione peroxidase (GPx-3) expression. J. Biol. Chem. 279, 26839-26845
66. Voetsch, B., Jin, R. C., Bierl, C., Benke, K. S., Kenet, G., Simioni, P., Ottaviano, F., Damasceno, B. P., Annichino-Bizacchi, J. M., Handy, D. E. and Loscalzo, J. (2007) Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 38, 41-49
67. Voetsch, B., Jin, R. C., Bierl, C., Deus-Silva, L., Camargo, E. C., Annichino-Bizacchi, J. M., Handy, D. E. and Loscalzo, J. (2008) Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke 39, 303-307
68. Guo, Z., Van Remmen, H., Yang, H., Chen, X., Mele, J., Vijg, J., Epstein, C. J., Ho, Y. S. and Richardson, A. (2001) Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxidized LDL-induced apoptosis in mouse aortic cells. Arterioscler. Thromb. Vasc. Biol. 21, 1131-1138
69. Hollander, J. M., Lin, K. M., Scott, B. T. and Dillmann, W. H. (2003) Overexpression of PHGPx and HSP60/10 protects against ischemia/ reoxygenation injury. Free Radical Biol. Med. 35, 742-751
70. Seiler, A., Schneider, M., Forster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Radmark, O., Wurst, W. et al. (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/ 15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8, 237-248
71. Berndt, C., Lillig, C. H. and Holmgren, A. (2007) Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 292, H1227-H1236
72. World, C. J., Yamawaki, H. and Berk, B. C. (2006) Thioredoxin in the cardiovascular system. J. Mol. Med. 84, 997-1003
73. Ago, T. and Sadoshima, J. (2006) Thioredoxin and ventricular remodeling. J. Mol. Cell. Cardiol. 41, 762-773
74. Arner, E. S. and Holmgren, A. (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109
75. Maulik, N. and Das, D. K. (2008) Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim. Biophys. Acta 1780, 1368-1382
76. Pimentel, D. R., Adachi, T., Ido, Y., Heibeck, T., Jiang, B., Lee, Y., Melendez, J. A., Cohen, R. A. and Colucci, W. S. (2006) Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J. Mol. Cell. Cardiol. 41, 613-622
77. Amin, J. K., Xiao, L., Pimental, D. R., Pagano, P. J., Singh, K., Sawyer, D. B. and Colucci, W. S. (2001) Reactive oxygen species mediate α-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 33, 131-139
78. Tanaka, K., Honda, M. and Takabatake, T. (2001) Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J. Am. Coll. Cardiol. 37, 676-685
79. Nakamura, K., Fushimi, K., Kouchi, H., Mihara, K., Miyazaki, M., Ohe, T. and Namba, M. (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II. Circulation 98, 794-799
80. Remondino, A., Kwon, S. H., Communal, C., Pimentel, D. R., Sawyer, D. B., Singh, K. and Colucci, W. S. (2003) β-Adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ. Res. 92, 136-138
81. Kuster, G. M., Pimentel, D. R., Adachi, T., Ido, Y., Brenner, D. A., Cohen, R. A., Liao, R., Siwik, D. A. and Colucci, W. S. (2005) α-Adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 111, 1192-1198
82. Andersson, M., Holmgren, A. and Spyrou, G. (1996) NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase: implication for a protective mechanism against NK-lysin cytotoxicity. J. Biol. Chem. 271, 10116-10120
83. Lu, C., Qiu, F., Zhou, H., Peng, Y., Hao, W., Xu, J., Yuan, J., Wang, S., Qiang, B., Xu, C. and Peng, X. (2006) Identification and characterization of selenoprotein K: an antioxidant in cardiomyocytes. FEBS Lett. 580, 5189-5197
84. Burk, R. F. and Hill, K. E. (2009) Selenoprotein P: expression, functions, and roles in mammals. Biochim. Biophys. Acta, doi:10.1016/ j.bbagen.2009.03.026
85. Arteel, G. E., Mostert, V., Oubrahim, H., Briviba, K., Abel, J. and Sies, H. (1998) Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biol. Chem. 379, 1201-1205
86. Takebe, G., Yarimizu, J., Saito, Y., Hayashi, T., Nakamura, H., Yodoi, J., Nagasawa, S. and Takahashi, K. (2002) A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J. Biol. Chem. 277, 41254-41258
87. Li, G. S., Wang, F., Kang, D. and Li, C. (1985) Keshan disease: an endemic cardiomyopathy in China. Hum. Pathol. 16, 602-609
88. Xu, G. L., Wang, S. C., Gu, B. Q., Yang, Y. X., Song, H. B., Xue, W. L., Liang, W. S. and Zhang, P. Y. (1997) Further investigation on the role of selenium deficiency in the aetiology and pathogenesis of Keshan disease. Biomed. Environ. Sci. 10, 316-326
89. Li, Y., Yang, Y. and Chen, H. (1995) Detection of enteroviral RNA in paraffin-embedded myocardial tissue from patients with Keshan by nested PCR. Zhonghua Yixue Zazhi 75, 344-345, 382
90. Peng, T., Li, Y., Yang, Y., Niu, C., Morgan-Capner, P., Archard, L. C. and Zhang, H. (2000) Characterization of enterovirus isolates from patients with heart muscle disease in a selenium-deficient area of China. J. Clin. Microbiol. 38, 3538-3543
91. Keshan Disease Research Group (1979) Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin. Med. J. (Beijing Engl. Ed.) 92, 477-482
92. Beck, M. A., Kolbeck, P. C., Rohr, L. H., Shi, Q., Morris, V. C. and Levander, O. A. (1994) Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol. 43, 166-170
93. Beck, M. A., Kolbeck, P. C., Shi, Q., Rohr, L. H., Morris, V. C. and Levander, O. A. (1994) Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. J. Infect. Dis. 170, 351-357
94. Beck, M. A., Esworthy, R. S., Ho, Y. S. and Chu, F. F. (1998) Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J. 12, 1143-1149
95. Beck, M. A. and Matthews, C. C. (2000) Micronutrients and host resistance to viral infection. Proc. Nutr. Soc. 59, 581-585
96. Rossi, M. A. and Bestetti, R. B. (1995) The challenge of chagasic cardiomyopathy: the pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications. Cardiology 86, 1-7
97. Rivera, M. T., de Souza, A. P., Moreno, A. H., Xavier, S. S., Gomes, J. A., Rocha, M. O., Correa-Oliveira, R., Neve, J., Vanderpas, J. and Araujo-Jorge, T. C. (2002) Progressive Chagas' cardiomyopathy is associated with low selenium levels. Am. J. Trop. Med. Hyg. 66, 706-712
98. Salonen, J. T., Alfthan, G., Huttunen, J. K., Pikkarainen, J. and Puska, P. (1982) Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 2, 175-179
99. Virtamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J. K. and Karvonen, M. J. (1985) Serum selenium and the risk of coronary heart disease and stroke. Am. J. Epidemiol. 122, 276-282
100. Akbaraly, N. T., Arnaud, J., Hininger-Favier, I., Gourlet, V., Roussel, A. M. and Berr, C. (2005) Selenium and mortality in the elderly: results from the EVA study. Clin. Chem. 51, 2117-2123
101. Kok, F. J., de Bruijn, A. M., Vermeeren, R., Hofman, A., van Laar, A., de Bruin, M., Hermus, R. J. and Valkenburg, H. A. (1987) Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am. J. Clin. Nutr. 45, 462-468
102. Neve, J. (1996) Selenium as a risk factor for cardiovascular diseases. J. Cardiovasc. Risk 3, 42-47
103. Salvini, S., Hennekens, C. H., Morris, J. S., Willett, W. C. and Stampfer, M. J. (1995) Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians. Am. J. Cardiol. 76, 1218-1221
104. Suadicani, P., Hein, H. O. and Gyntelberg, F. (1992) Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 96, 33-42
105. Kardinaal, A. F., Kok, F. J., Kohlmeier, L., Martin-Moreno, J. M., Ringstad, J., Gómez-Aracena, J., Mazaev, V. P., Thamm, M., Martin, B. C., Aro, A. et al. (1997) Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. European Antioxidant Myocardial Infarction and Breast Cancer. Am. J. Epidemiol. 145, 373-379
106. Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K. and Sethi, G. (2006) Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72, 1605-1621
107. Hold, G. L. and El-Omar, M. E. (2008) Genetic aspects of inflammation and cancer. Biochem. J. 410, 225-235
108. Khanna, D., Sethi, G., Ahn, K. S., Pandey, M. K., Kunnumakkara, A. B., Sung, B., Aggarwal, A. and Aggarwal, B. B. (2007) Natural products as a gold mine for arthritis treatment. Curr. Opin. Pharmacol. 7, 344-351
109. Cook, D. N., Beck, M. A., Coffman, T. M., Kirby, S. L., Sheridan, J. F., Pragnell, I. B. and Smithies, O. (1995) Requirement of MIP-1α for an inflammatory response to viral infection. Science 269, 1583-1585
110. Packard, R. R. and Libby, P. (2008) Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 54, 24-38
111. Robinson, L. E., Buchholz, A. C. and Mazurak, V. C. (2007) Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome. Appl. Physiol. Nutr. Metab. 32, 1008-1024
112. Wyss-Coray, T. and Mucke, L. (2002) Inflammation in neurodegenerative disease: a double-edged sword. Neuron 35, 419-432
113. McCord, J. M. (2000) The evolution of free radicals and oxidative stress. Am. J. Med. 108, 652-659
114. Hoffmann, P. R. (2007) Mechanisms by which selenium influences immune responses. Arch. Immunol. Ther. Exp. 55, 289-297
115. Shrimali, R. K., Irons, R. D., Carlson, B. A., Sano, Y., Gladyshev, V. N., Park, J. M. and Hatfield, D. L. (2008) Selenoproteins mediate T cell immunity through an antioxidant mechanism. J. Biol. Chem. 283, 20181-20185
116. Roy, M., Kiremidjian-Schumacher, L., Wishe, H. I., Cohen, M. W. and Stotzky, G. (1993) Selenium supplementation enhances the expression of interleukin 2 receptor subunits and internalization of interleukin 2. Proc. Soc. Exp. Biol. Med. 202, 295-301
117. Beck, M. A., Nelson, H. K., Shi, Q., Van Dael, P., Schiffrin, E. J., Blum, S., Barclay, D. and Levander, O. A. (2001) Selenium deficiency increases the pathology of an influenza virus infection. FASEB J. 15, 1481-1483
118. Prabhu, K. S., Zamamiri-Davis, F., Stewart, J. B., Thompson, J. T., Sordillo, L. M. and Reddy, C. C. (2002) Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-?B in up-regulation. Biochem. J. 366, 203-209
119. Vunta, H., Davis, F., Palempalli, U. D., Bhat, D., Arner, R. J., Thompson, J. T., Peterson, D. G., Reddy, C. C. and Prabhu, K. S. (2007) The anti-inflammatory effects of selenium are mediated through 15-deoxy-d12,14-prostaglandin J2 in macrophages. J. Biol. Chem. 282, 17964-17973
120. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. and Glass, C. K. (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82
121. Bailey, S. T. and Ghosh, S. (2005) 'PPAR'ting ways with inflammation. Nat. Immunol. 6, 966-967
122. Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G. and Glass, C. K. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437, 759-763
123. Nelson, H. K., Shi, Q., Van Dael, P., Schiffrin, E. J., Blum, S., Barclay, D., Levander, O. A. and Beck, M. A. (2001) Host nutritional selenium status as a driving force for influenza virus mutations. FASEB J. 15, 1846-1848
124. Hori, K., Hatfield, D., Maldarelli, F., Lee, B. J. and Clouse, K. A. (1997) Selenium supplementation suppresses tumor necrosis factor α-induced human immunodeficiency virus type 1 replication in vitro. AIDS Res. Hum. Retroviruses 13, 1325-1332
125. Kalantari, P., Narayan, V., Natarajan, S. K., Muralidhar, K., Gandhi, U. H., Vunta, H., Henderson, A. J. and Prabhu, K. S. (2008) Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages. J. Biol. Chem. 283, 33183-33190
126. Yu, S. Y., Zhu, Y. J. and Li, W. G. (1997) Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol. Trace Elem. Res. 56, 117-124
127. Forceville, X., Vitoux, D., Gauzit, R., Combes, A., Lahilaire, P. and Chappuis, P. (1998) Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit. Care Med. 26, 1536-1544
128. Forceville, X., Laviolle, B., Annane, D., Vitoux, D., Bleichner, G., Korach, J. M., Cantais, E., Georges, H., Soubirou, J. L., Combes, A. and Bellissant, E. (2007) Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit. Care 11, R73
129. Berger, M. M., Soguel, L., Shenkin, A., Revelly, J. P., Pinget, C., Baines, M. and Chiolero, R. L. (2008) Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit. Care 12, R101
130. Ye, Y., Shibata, Y., Yun, C., Ron, D. and Rapoport, T. A. (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429, 841-847
131. Ye, Y., Shibata, Y., Kikkert, M., van Voorden, S., Wiertz, E. and Rapoport, T. A. (2005) Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. U.S.A. 102, 14132-14138
132. Gao, Y., Pagnon, J., Feng, H. C., Konstantopolous, N., Jowett, J. B., Walder, K. and Collier, G. R. (2007) Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells. Biochem. Biophys. Res. Commun. 356, 636-641
133. Gao, Y., Hannan, N. R., Wanyonyi, S., Konstantopolous, N., Pagnon, J., Feng, H. C., Jowett, J. B., Kim, K. H., Walder, K. and Collier, G. R. (2006) Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 33, 246-251
134. Kim, K. H., Gao, Y., Walder, K., Collier, G. R., Skelton, J. and Kissebah, A. H. (2007) SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis. Biochem. Biophys. Res. Commun. 354, 127-132
135. Fradejas, N., Pastor, M. D., Mora-Lee, S., Tranque, P. and Calvo, S. (2008) SEPS1 gene is activated during astrocyte ischemia and shows prominent antiapoptotic effects. J. Mol. Neurosci. 35, 259-265
136. Curran, J. E., Jowett, J. B., Elliott, K. S., Gao, Y., Gluschenko, K., Wang, J., Abel Azim, D. M., Cai, G., Mahaney, M. C., Comuzzie, A. G. et al. (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37, 1234-1241
137. Silander, K., Alanne, M., Kristiansson, K., Saarela, O., Ripatti, S., Auro, K., Karvanen, J., Kulathinal, S., Niemela, M., Ellonen, P. et al. (2008) Gender differences in genetic risk profiles for cardiovascular disease. PLoS ONE 3, e3615
138. Moses, E. K., Johnson, M. P., Tommerdal, L., Forsmo, S., Curran, J. E., Abraham, L. J., Charlesworth, J. C., Brennecke, S. P., Blangero, J. and Austgulen, R. (2008) Genetic association of preeclampsia to the inflammatory response gene SEPS1. Am. J. Obstet. Gynecol. 198, 336.e1-336.e5
139. Alanne, M., Kristiansson, K., Auro, K., Silander, K., Kuulasmaa, K., Peltonen, L., Salomaa, V. and Perola, M. (2007) Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts. Hum. Genet. 122, 355-365
140. Shibata, T., Arisawa, T., Tahara, T., Ohkubo, M., Yoshioka, D., Maruyama, N., Fujita, H., Kamiya, Y., Nakamura, M., Nagasaka, M. et al. (2009) Selenoprotein S (SEPS1) gene -105G>A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterol. 9, 2
141. Marinou, I., Walters, K., Dickson, M. C., Binks, M. H., Bax, D. E. and Wilson, A. G. (2008) Evidence of epistasis between interleukin-1 and selenoprotein-S with susceptibility to RA. Ann. Rheum. Dis., doi:10.1136/ ard.2008.090001
142. Hyrenbach, S., Pezzini, A., del Zotto, E., Giossi, A., Lichy, C., Kloss, M., Werner, I., Padovani, A., Brandt, T. and Grond-Ginsbach, C. (2007) No association of the - 105 promoter polymorphism of the selenoprotein S encoding gene SEPS1 with cerebrovascular disease. Eur. J. Neurol. 14, 1173-1175
143. Martinez, A., Santiago, J. L., Varade, J., Marquez, A., Lamas, J. R., Mendoza, J. L., de la Calle, H., Diaz-Rubio, M., de la Concha, E. G., Fernandez-Gutierrez, B. and Urcelay, E. (2008) Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases. BMC Genomics 9, 329
144. Seiderer, J., Dambacher, J., Kuhnlein, B., Pfennig, S., Konrad, A., Torok, H. P., Haller, D., Goke, B., Ochsenkuhn, T., Lohse, P. and Brand, S. (2007) The role of the selenoprotein S (SELS) gene - 105G > A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation. Tissue Antigens 70, 238-246
145. Hatfield, D. L., Yoo, M. H., Carlson, B. A. and Gladyshev, V. N. (2009) Selenoproteins that function in cancer prevention and promotion. Biochim. Biophys. Acta, doi:10.1016/j.bbagen.2009.03.001
146. Jackson, M. I. and Combs, Jr, G. F. (2008) Selenium and anticarcinogenesis: underlying mechanisms. Curr. Opin. Clin. Nutr. Metab. Care 11, 718-726
147. Brigelius-Flohé, R. (2008) Selenium compounds and selenoproteins in cancer. Chem. Biodivers. 5, 389-395
148. Squires, J. and Berry, M. J. (2006) Selenium, selenoproteins, and cancer. Hawaii Med. J. 65, 239-240
149. Diwadkar-Navsariwala, V. and Diamond, A. M. (2004) The link between selenium and chemoprevention: a case for selenoproteins. J. Nutr. 134, 2899-2902
150. Stranges, S., Marshall, J. R., Natarajan, R., Donahue, R. P., Trevisan, M., Combs, G. F., Cappuccio, F. P., Ceriello, A. and Reid, M. E. (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Intern. Med. 147, 217-223
151. Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., Ford, L. G., Parnes, H. L., Minasian, L. M., Gaziano, J. M., Hartline, J. A. et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, J. Am. Med. Assoc. 301, 39-51
152. Foster, C. B., Aswath, K., Chanock, S. J., McKay, H. F. and Peters, U. (2006) Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet. 7, 56
153. Hu, Y., Benya, R. V., Carroll, R. E. and Diamond, A. M. (2005) Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J. Nutr. 135, 3021S-3024S
154. Hu, Y. J. and Diamond, A. M. (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 63, 3347-3351
155. Al-Taie, O. H., Uceyler, N., Eubner, U., Jakob, F., Mork, H., Scheurlen, M., Brigelius-Flohé, R., Schottker, K., Abel, J., Thalheimer, A. et al. (2004) Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr. Cancer 48, 6-14
156. Bermano, G., Pagmantidis, V., Holloway, N., Kadri, S., Mowat, N. A., Shiel, R. S., Arthur, J. R., Mathers, J. C., Daly, A. K., Broom, J. and Hesketh, J. E. (2007) Evidence that a polymorphism within the 3′UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutr. 2, 225-232
157. Jablonska, E., Gromadzinska, J., Sobala, W., Reszka, E. and Wasowicz, W. (2008) Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur. J. Nutr. 47, 47-54
158. Reference deleted
159. Cooper, M. L., Adami, H. O., Gronberg, H., Wiklund, F., Green, F. R. and Rayman, M. P. (2008) Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res. 68, 10171-10177
160. Clark, L. C., Combs, Jr, G. F., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G. et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, J. Am. Med. Assoc. 276, 1957-1963
161. Duffield-Lillico, A. J., Dalkin, B. L., Reid, M. E., Turnbull, B. W., Slate, E. H., Jacobs, E. T., Marshall, J. R. and Clark, L. C. (2003) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 91, 608-612
162. Barnes, K. M., Evenson, J. K., Raines, A. M. and Sunde, R. A. (2009) Transcript analysis of the selenoproteome indicates that dietary selenium requirements of rats based on selenium-regulated selenoprotein mRNA levels are uniformly less than those based on glutathione peroxidase activity. J. Nutr. 139, 199-206
163. Sunde, R. A., Raines, A. M., Barnes, K. M. and Evenson, J. K. (2008) Selenium status highly-regulates selenoprotein mRNA levels for only a subset of the selenoproteins in the selenoproteome. Biosci. Rep. 29, 329-338
164. Behne, D., Hilmert, H., Scheid, S., Gessner, H. and Elger, W. (1988) Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim. Biophys. Acta 966, 12-21
165. Nakayama, A., Hill, K. E., Austin, L. M., Motley, A. K. and Burk, R. F. (2007) All regions of mouse brain are dependent on selenoprotein P for maintenance of selenium. J. Nutr. 137, 690-693
166. Chen, J. and Berry, M. J. (2003) Selenium and selenoproteins in the brain and brain diseases. J. Neurochem. 86, 1-12
167. Moreira, P. I., Honda, K., Zhu, X., Nunomura, A., Casadesus, G., Smith, M. A. and Perry, G. (2006) Brain and brawn: parallels in oxidative strength. Neurology 66, S97-S101
168. Reddy, P. H. and Beal, M. F. (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res. Rev. 49, 618-632
169. Kowalska, A., Pruchnik-Wolinska, D., Florczak, J., Modestowicz, R., Szczech, J., Kozubski, W., Rossa, G. and Wender, M. (2004) Genetic study of familial cases of Alzheimer's disease. Acta Biochim. Pol. 51, 245-252
170. Hwang, D. Y., Cho, J. S., Oh, J. H., Shim, S. B., Jee, S. W., Lee, S. H., Seo, S. J., Lee, S. K., Lee, S. H. and Kim, Y. K. (2005) Differentially expressed genes in transgenic mice carrying human mutant presenilin-2 (N141I): correlation of selenoprotein M with Alzheimer's disease. Neurochem. Res. 30, 1009-1019
171. Scharpf, M., Schweizer, U., Arzberger, T., Roggendorf, W., Schomburg, L. and Köhrle, J. (2007) Neuronal and ependymal expression of selenoprotein P in the human brain. J. Neural Transm. 114, 877-884
172. Lu, T., Pan, Y., Kao, S. Y., Li, C., Kohane, I., Chan, J. and Yankner, B. A. (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891
173. Peters, M. M., Hill, K. E., Burk, R. F. and Weeber, E. J. (2006) Altered hippocampus synaptic function in selenoprotein P deficient mice. Mol. Neurodegener. 1, 12
174. Miller, J. A., Oldham, M. C. and Geschwind, D. H. (2008) A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J. Neurosci. 28, 1410-1420
175. Bellinger, F. P., He, Q. P., Bellinger, M. T., Lin, Y., Raman, A. V., White, L. R. and Berry, M. J. (2008) Association of selenoprotein P with Alzheimer's pathology in human cortex. J. Alzheimers Dis. 15, 465-472
176. Strozyk, D., Launer, L. J., Adlard, P. A., Cherny, R. A., Tsatsanis, A., Volitakis, I., Blennow, K., Petrovitch, H., White, L. R. and Bush, A. I. (2009) Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid. Neurobiol. Aging 30, 1069-1077
177. Lovell, M. A., Xiong, S., Lyubartseva, G. and Markesbery, W. R. (2009) Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. Free Radical Biol. Med. 46, 1527-1533
178. Kryscio, R. J., Mendiondo, M. S., Schmitt, F. A. and Markesbery, W. R. (2004) Designing a large prevention trial: statistical issues. Stat. Med. 23, 285-296
179. Chinta, S. J. and Andersen, J. K. (2005) Dopaminergic neurons. Int. J. Biochem. Cell Biol. 37, 942-946
180. Iversen, S. D. and Iversen, L. L. (2007) Dopamine: 50 years in perspective. Trends Neurosci. 30, 188-193
181. Fahn, S. (2003) Description of Parkinson's disease as a clinical syndrome. Ann. N.Y. Acad. Sci. 991, 1-14
182. Galvin, J. E. (2006) Interaction of α-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra. Acta Neuropathol. 112, 115-126
183. Chen, J. and Berry, M. J. (2003) Selenium and selenoproteins in the brain and brain diseases. J. Neurochem. 86, 1-12
184. Kim, H. C., Jhoo, W. K., Choi, D. Y., Im, D. H., Shin, E. J., Suh, J. H., Floyd, R. A. and Bing, G. (1999) Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res. 851, 76-86
185. Imam, S. Z., Newport, G. D., Islam, F., Slikker, Jr, W. and Ali, S. F. (1999) Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res. 818, 575-578
186. Imam, S. Z. and Ali, S. F. (2000) Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res. 855, 186-191
187. Virmani, A., Gaetani, F., Imam, S., Binienda, Z. and Ali, S. (2003) Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. Ann. N.Y. Acad. Sci. 993, 197-207
188. Zeevalk, G. D., Razmpour, R. and Bernard, L. P. (2008) Glutathione and Parkinson's disease: is this the elephant in the room? Biomed. Pharmacother. 62, 236-249
189. Kim, H., Jhoo, W., Shin, E. and Bing, G. (2000) Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss: comparison with MPTP model. Brain Res. 862, 247-252
190. Zafar, K. S., Siddiqui, A., Sayeed, I., Ahmad, M., Salim, S. and Islam, F. (2003) Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J. Neurochem. 84, 438-446
191. Islam, F., Zia, S., Sayeed, I., Zafar, K. S. and Ahmad, A. S. (2002) Selenium-induced alteration of lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat. Biol. Trace Elem. Res. 90, 203-214
192. Power, J. H. and Blumbergs, P. C. (2009) Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol. 117, 63-73
193. Klivenyi, P., Starkov, A. A., Calingasan, N. Y., Gardian, G., Browne, S. E., Yang, L., Bubber, P., Gibson, G. E., Patel, M. S. and Beal, M. F. (2004) Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J. Neurochem. 88, 1352-1360
194. Bensadoun, J. C., Mirochnitchenko, O., Inouye, M., Aebischer, P. and Zurn, A. D. (1998) Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur. J. Neurosci. 10, 3231-3236
195. Ridet, J. L., Bensadoun, J. C., Deglon, N., Aebischer, P. and Zurn, A. D. (2006) Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease. Neurobiol. Dis. 21, 29-34
196. Fisher, R. S., van Emde Boas, W., Blume, W., Elger, C., Genton, P., Lee, P. and Engel, Jr, J. (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46, 470-472
197. Ashrafi, M. R., Shabanian, R., Abbaskhanian, A., Nasirian, A., Ghofrani, M., Mohammadi, M., Zamani, G. R., Kayhanidoost, Z., Ebrahimi, S. and Pourpak, Z. (2007) Selenium and intractable epilepsy: is there any correlation? Pediatr. Neurol. 36, 25-29
198. Savaskan, N. E., Brauer, A. U., Kuhbacher, M., Eyupoglu, I. Y., Kyriakopoulos, A., Ninnemann, O., Behne, D. and Nitsch, R. (2003) Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. FASEB J. 17, 112-114
199. 2+-ATPase activity, and EEG records in pentylentetrazol-induced seizures in rats. J. Membr. Biol. 225, 39-49
200. Kutluhan, S., Naziroglu, M., Celik, O. and Yilmaz, M. (2009) Effects of selenium and topiramate on lipid peroxidation and antioxidant vitamin levels in blood of pentylentetrazol-induced epileptic rats. Biol. Trace Elem. Res. 129, 181-189
201. Schomburg, L., Schweizer, U., Holtmann, B., Flohé, L., Sendtner, M. and Köhrle, J. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370, 397-402
202. Hill, K. E., Zhou, J., McMahan, W. J., Motley, A. K., Atkins, J. F., Gesteland, R. F. and Burk, R. F. (2003) Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem. 278, 13640-13646
203. Larsen, P. R. and Berry, M. J. (1995) Nutritional and hormonal regulation of thyroid hormone deiodinases. Annu. Rev. Nutr. 15, 323-352
204. Visser, T. J. (1996) Pathways of thyroid hormone metabolism. Acta Med. Austriaca 23, 10-16
205. Dumitrescu, A. M., Liao, X. H., Abdullah, M. S., Lado-Abeal, J., Majed, F. A., Moeller, L. C., Boran, G., Schomburg, L., Weiss, R. E. and Refetoff, S. (2005) Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37, 1247-1252
206. Schweizer, U., Schomburg, L. and Savaskan, N. E. (2004) The neurobiology of selenium: lessons from transgenic mice. J. Nutr. 134, 707-710
207. Avery, L. (1998) Diabetes mellitus types 1 and 2: an overview. Nurs. Stand. 13, 35-38
208. Roberts, C. K. and Sindhu, K. K. (2009) Oxidative stress and metabolic syndrome. Life Sci. 84, 705-712
209. Aydemir-Koksoy, A. and Turan, B. (2008) Selenium inhibits proliferation signaling and restores sodium/potassium pump function of diabetic rat aorta. Biol. Trace Elem. Res. 126, 237-245
210. Ozdemir, S., Ayaz, M., Can, B. and Turan, B. (2005) Effect of selenite treatment on ultrastructural changes in experimental diabetic rat bones. Biol. Trace Elem. Res. 107, 167-179
211. Faure, P. (2003) Protective effects of antioxidant micronutrients (vitamin E, zinc and selenium) in type 2 diabetes mellitus. Clin. Chem. Lab. Med. 41, 995-998
212. Battell, M. L., Delgatty, H. L. and McNeill, J. H. (1998) Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats. Mol. Cell. Biochem. 179, 27-34
213. Bleys, J., Navas-Acien, A. and Guallar, E. (2007) Serum selenium and diabetes in U.S. adults. Diabetes Care 30, 829-834
214. Ghosh, R., Mukherjee, B. and Chatterjee, M. (1994) A novel effect of selenium on streptozotocin-induced diabetic mice. Diabetes Res. 25, 165-171
215. McNeill, J. H., Delgatty, H. L. and Battell, M. L. (1991) Insulinlike effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes 40, 1675-1678
216. Karlsson, H. K., Tsuchida, H., Lake, S., Koistinen, H. A. and Krook, A. (2004) Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects. Diabetes 53, 1424-1428
217. Walder, K., Kantham, L., McMillan, J. S., Trevaskis, J., Kerr, L., De Silva, A., Sunderland, T., Godde, N., Gao, Y., Bishara, N. et al. (2002) Tanis: a link between type 2 diabetes and inflammation? Diabetes 51, 1859-1866
218. McClung, J. P., Roneker, C. A., Mu, W., Lisk, D. J., Langlais, P., Liu, F. and Lei, X. G. (2004) Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. U.S.A. 101, 8852-8857
219. Sunde, R. A., Evenson, J. K., Thompson, K. M. and Sachdev, S. W. (2005) Dietary selenium requirements based on glutathione peroxidase-1 activity and mRNA levels and other Se-dependent parameters are not increased by pregnancy and lactation in rats. J. Nutr. 135, 2144-2150
220. Jones, C. Y., Tang, A. M., Forrester, J. E., Huang, J., Hendricks, K. M., Knox, T. A., Spiegelman, D., Semba, R. D. and Woods, M. N. (2006) Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J. Acquir. Immune Defic. Syndr. 43, 475-482